Proposed consolidation of securities
Filed with ASX · · 2 pages · English
Earlier from Anagenics
- Cellmid receives $947K R&D tax credit
- Cellmid completes US consumer study
- Cellmid secures premium US retail channel for evolis
- Nature Paper MK in Melanoma
- Cellmids FGF5 inhibitor clinical study published
Later from Anagenics
- Cellmid opens first concept store in tokyo
- Cellmid secures new US retail partner for evolis
- Cellmid placement to strategic investor
- Cellmid quarterly operational update
- Record 2M sales for Cellmid FGF5 inhibitors
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics